Research Article
Comparison of Different Measures of Fat Mass and Their Association with Serum Cystatin C Levels
Table 1
Patient characteristics (
).
| | Variable | Statistic* |
| | Age (years) | 53.5 ± 15.1 | | Men (, %) | 171 (51.0) | | Chinese | 129 (38.5) | | Indian | 79 (23.6) | | Malay | 99 (29.6) | | Others | 28 (8.4) | | Diabetes (, %) | 119 (35.5) | | Hypertension (, %) | 192 (57.3) | | Coronary artery disease (, %) | 54 (16.1) | | Cerebrovascular disease (, %) | 10 (3.0) | | Systolic BP (SBP, mmHg) | 128 ± 22 | | Diastolic BP (DBP, mmHg) | 71 ± 10 | | Height (m) | 1.60 ± 0.09 | | Weight (kg) | 68.9 ± 15.1 | | Body Mass Index (BMI; kg/m2) | 26.8 ± 5.21 | | Triceps skin-fold thickness (TSF, cm) | 2.61 ± 1.04 | | Measured GFR (mL/min per 1.73 m2) | 67 ± 33 | | Serum creatinine (mg/dL) | 1.44 ± 0.972 | | Serum cystatin C (mg/L) | 1.27 ± 0.66 | | Serum albumin (g/L) | 42.3 ± 3.1 | | Serum C-reactive protein (mg/L) | 5.0 (5.0-5.0) | | Serum urea (mmol/L) | 6.0 (4.0–10.6) | | 24-hr urine total protein (g/day) | 0.14 (0.08–0.39) | | 24-hr urine phosphate (mmol/day) | 14.6 ± 7.78 | | 24-hr urine urea nitrogen (g/day) | 6.77 ± 2.91 | | Phosphate binders use (, %) | 214 (16) | | Percentage body fat (Bioimpedance) | 34.1 ± 9.53 | | Waist-hip ratio | 0.89 ± 0.07 |
|
|
Data is reported as mean ± SD, or median (25%–75%), or frequency (%).
|
